1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-147682
    NF-κB-IN-5 Inhibitor
    NF-κB-IN-5 (化合物 4d) 是一种口服有效的 NF-κB 抑制剂,与 NF-κB 直接相互作用。NF-κB-IN-5 对人癌细胞株 (HCT116、U87-MG、HepG2、BGC823、PC9) 具有明显的抗肿瘤活性,其 IC50 分别为 5.35、2.81、2.83、2.02 和 3.90 μM。NF-κB-IN-5 诱导 U87-MG 肿瘤细胞凋亡,细胞周期阻滞在 G0/G1 期。
    NF-κB-IN-5
  • HY-15027S2
    5-Aminosalicylic acid-13C6

    美沙拉嗪-13C6

    5-Aminosalicylic acid-13C613C 标记的 5-Aminosalicylic Acid。 5-Aminosalicylic acid (Mesalamine) 是一种特异性的 PPARγ 激动剂,还抑制 p21-激活激酶1 (PAK1) 和 NF-κB
    5-Aminosalicylic acid-<sup>13</sup>C<sub>6</sub>
  • HY-P10350
    PapRIV Agonist
    PapRIV 是 BV-2 小胶质细胞的激动剂,能够通过 NF-κB 依赖的路径激活小胶质细胞。PapRIV 诱导了 IL-6 和 TNFα 等促炎细胞因子的表达,并增加了活性氧 (ROS) 的产生。PapRIV 可以通过血脑屏障。
    PapRIV
  • HY-138284
    Avenanthramide-C methyl ester Inhibitor
    Avenanthramide-C methyl ester 是一种抗炎剂和 NF-κB 抑制剂,可抑制促炎因子分泌。Avenanthramide-C methyl ester 通过抑制 IKK 和 IκB 磷酸化以及抑制蛋白酶体活性,抑制 NF-κB 激活。
    Avenanthramide-C methyl ester
  • HY-145491
    Resolvin D5
    Resolvin D5 是一种具有抗炎活性的促溶解介质 (SPM),源自 DHA 的氧化脂质。Resolvin D5 抑制 Th17 细胞分化并促进调节性 T 细胞分化,并抑制 CD4+ T 细胞增殖。Resolvin D5 减弱破骨细胞分化并干扰破骨细胞生成。Resolvin D5 还调节 ERK 的磷酸化和 NF-kappaB 的核转位。Resolvin D5 可用于类风湿性关节炎的研究
    Resolvin D5
  • HY-15122R
    Sinomenine (Standard)

    青藤碱 (Standard)

    Inhibitor
    Sinomenine (Standard)是 Sinomenine 的分析标准品。本产品用于研究及分析应用。Sinomenine 是来自?Sinomenium acutum 的一种生物碱,是 NF-κB 活化的阻断剂。Sinomenine 也是 μ 阿片受体 (μ-opioid receptor) 激活剂。
    Sinomenine (Standard)
  • HY-N10009
    Cudraflavone B Modulator
    Cudraflavone B 是一种异戊二烯化类黄酮,具有抗炎和抗癌特性。Cudraflavone B 也是 COX-1COX-2 的双重抑制剂。Cudraflavone B 阻断巨噬细胞中 核因子 κB (NF-κB) 从细胞质到细胞核的易位。由此,Cudraflavone B 也抑制肿瘤坏死因子 α (TNFα) 的基因表达和分泌。Cudraflavone B 还触发线粒体凋亡通路,激活 NF-κB、MAPK p38ERK,并诱导 SIRT1 的表达。由此,Cudraflavone B 抑制人口腔鳞状细胞癌细胞的生长。
    Cudraflavone B
  • HY-N8884
    Coelonin Inhibitor
    Coelonin 是一种具有抗炎活性的二氢菲。Coelonin 可抑制 LPS 诱导的 PTEN 磷酸化。Coelonin 通过负向调节 PI3K/AKT 通路抑制 NF-κB 激活和 p27Kip1 降解。Coelonin 可抑制 IκBα 的磷酸化和降解,增加 IκBα 蛋白的表达。
    Coelonin
  • HY-N3188
    Niloticin Inhibitor ≥98.0%
    Niloticin 为四环三萜化合物,是一种破骨细胞生成 (osteoclastogenesis) 抑制剂。Niloticin 具有抗病毒、抗氧化和灭蚊活性。Niloticin 通过阻断 RANKL-RANK 相互作用、抑制 AKTMAPKNF-κB 信号通路抑制破骨细胞形成。
    Niloticin
  • HY-150587
    Anti-inflammatory agent 31 Inhibitor
    Anti-inflammatory agent 31 是一种穿心莲内酯衍生物,是一种抗炎剂 (anti-inflammatory agent)。Anti-inflammatory agent 31 通过上游阻断 PI3K/AktERK1/2 MAPK 激活来抑制 NF-kB 激活。Anti-inflammatory agent 31 能够恢复细胞内 GSH 水平并对肝脏具有保护作用。
    Anti-inflammatory agent 31
  • HY-W041489R
    Chelidonic acid (Standard)

    白屈菜酸 (Standard)

    Inhibitor
    Chelidonic acid (Standard) 是 Chelidonic acid 的分析标准品。本产品用于研究及分析应用。Chelidonic acid 是从 Chelidonium majus L. 中分到的酸类物质,为一种抗菌剂。Chelidonic acid 具有抗炎作用,可能通过抑制 NF-κBcaspase-1 来降低 IL-6 的产生。Chelidonic acid 为 glutamate decarboxylase 抑制剂,Ki 值为 1.2 μM。
    Chelidonic acid (Standard)
  • HY-138956
    MAY0132 Inhibitor
    MAY0132 是一种有效的和选择性的 EPAC2 抑制剂,IC50 为 0.4 μM。MAY0132 能显著抑制 HMPVAdVRSV 的复制,减少病毒感染诱导的细胞因子/趋化因子产生,并抑制 NF-κB 激活。MAY0132 具有抗病毒的活性,可用于呼吸道病毒感染相关研究。
    MAY0132
  • HY-168567
    RIPK2-IN-6 Inhibitor
    RIPK2-IN-6 (Compound 15a) 是 RIPK 的抑制剂,可抑制 RIPK2 的磷酸化,从而抑制 NF-κBMAPK 信号通路。RIPK2-IN-6 在 in Dextran sodium sulfate (HY-116282C) 诱发的小鼠结肠炎模型中表现出抗炎和抗纤维化活性。
    RIPK2-IN-6
  • HY-139716
    IMD-catechol Modulator
    IMD-catechol 是一种新型的NF-κB免疫调节剂二聚体,可提高CT26小鼠结肠癌模型的疗效,同时产生最小的辅助毒性。
    IMD-catechol
  • HY-111214
    K-14585 Inhibitor
    K-14585 是一种肽竞争性 PAR2 拮抗剂。K-14585 可抑制 PAR2 依赖性 IL-8 的产生、NF-κB 磷酸化和 p38 信号传导。K-14585 可降低 SLIGKV (PAR2 激动剂多肽) 诱导的原代人角质形成细胞中的 Ca2+ 动员。
    K-14585
  • HY-N12527
    Hyperelamine A
    Hyperelamine A 是一种多环聚异戊二烯化酰基间苯三酚 (PPAP)。 Hyperelamine A 通过 TLR-4/NF κB 信号传导对 BV-2 细胞中 LPS 激活的 NO 产生具有抑制活性。
    Hyperelamine A
  • HY-P10551
    Apo A-I mimetic 5A peptide Inhibitor
    Apo A-I mimetic 5A peptide 是一种合成的肽类分子,根据天然存在的载脂蛋白A-I (Apo A-I) 的结构和功能设计的。Apo A-I mimetic 5A peptide 能够促进胆固醇从细胞内向外流出,有助于减少细胞内胆固醇的积累。Apo A-I mimetic 5A peptide 还显示出抗炎活性,能够降低血液和组织中的炎症标志物。Apo A-I mimetic 5A peptide 可用于心血管疾病的研究。
    Apo A-I mimetic 5A peptide
  • HY-N0498R
    Nitidine chloride (Standard)

    氯化两面针碱 (Standard)

    Inhibitor
    Nitidine (chloride) (Standard) 是 Nitidine (chloride) 的分析标准品。本产品用于研究及分析应用。Nitidine chloride 是可从Zanthoxylum nitidum (Roxb) DC 中分离得到一种具有抗疟疾活性的化合物。Nitidine chloride 通过多个靶点通路,发挥抗癌活性,如诱导凋亡,抑制STAT3、DNA拓扑异构酶1和2A、ERKc-Src/FAK 相关信号通路。Nitidine chloride通过MAPKNF-kB途径抑制Lps诱导的炎性细胞因子的产生。
    Nitidine chloride (Standard)
  • HY-N0106R
    (Rac)-Salvianic acid A (sodium) (Standard)

    (Rac)-丹参素钠 (Standard)

    Inhibitor
    (Rac)-Salvianic acid A (sodium) (Standard) 是 (Rac)-Salvianic acid A (sodium) 的分析标准品。本产品用于研究及分析应用。(Rac)-Salvianic acid A sodium 是 Salvianic acid A (HY-N1913) 的外消旋体。Salvianic acid A 是一种具有口服活性的酚类化合物,可诱导 Nrf2/HO-1 激活并抑制 NF-κB 通路,也可激活线粒体 (Mitochondrial Metabolism) 抗氧化防御系统。Salvianic acid A 具有抗炎、抗氧化、抗凋亡 (Apoptosis) 等作用,具有用于炎症和心脑血管等疾病研究的潜力。
    (Rac)-Salvianic acid A (sodium) (Standard)
  • HY-14654B
    Aspirin DL-lysine

    赖氨匹林

    Inhibitor
    Aspirin DL-lysine (ASA DL-lysine) 是一种含有赖氨酸的阿司匹林衍生物。Aspirin DL-lysine 抑制血小板中的环氧合酶 (COX),阻断了血栓素A2 (TXA2) 的合成,从而抑制血小板的聚集和激活。Aspirin DL-lysine 可用于对不稳定型心绞痛患者凝血酶生成的研究。
    Aspirin DL-lysine
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.